Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.
BACKGROUND: The candidate malaria vaccine RTS,S/AS01E has entered phase 3 trials, but data on long-term outcomes are limited. METHODS: For 4 years, we followed children who had been randomly assigned, at 5 to 17 months of age, to receive three doses of RTS,S/AS01E vaccine (223 children) or rabies va...
Главные авторы: | Olotu, A, Fegan, G, Wambua, J, Nyangweso, G, Awuondo, K, Leach, A, Lievens, M, Leboulleux, D, Njuguna, P, Peshu, N, Marsh, K, Bejon, P |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2013
|
Схожие документы
-
Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children
по: Olotu, A, и др.
Опубликовано: (2016) -
Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.
по: Olotu, A, и др.
Опубликовано: (2010) -
Estimating individual exposure to malaria using local prevalence of malaria infection in the field.
по: Olotu, A, и др.
Опубликовано: (2012) -
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
по: Bejon, P, и др.
Опубликовано: (2008) -
RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
по: Bejon, P, и др.
Опубликовано: (2009)